University of Colorado, Denver: Sclerosis trials

The registry lists 11 Sclerosis studies with University of Colorado, Denver as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 1Phase 3 1Phase 4 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS StudyCompletedNCT04754542Results posted
• Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)CompletedNCT03073603Phase 4Results posted
• Safety of Switching From Rituximab to Ocrelizumab in MS PatientsCompletedNCT02980042Phase 3Results posted
• Comparison of Rituximab Induction Therapy Followed by Glatiramer AcetateCompletedNCT01569451Phase 2Results posted
• Proximal Resistance Training for People With Multiple SclerosisCompletedNCT04548154Not applicable
• Risk Factors in Early Multiple SclerosisStatus unknownNCT03586986
• Strength Training to Improve Gait in People With Multiple SclerosisCompletedNCT03175133Not applicable
• Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?CompletedNCT02588053
• Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer AcetateCompletedNCT02307877
• Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)CompletedNCT01698086Not applicable
• Effects of Vestibular Rehabilitation on MS-related Fatigue: a Randomized Control TrialCompletedNCT01216137Not applicable